Disease/Infection News

RSS

Study reveals strong link between infection rates and authoritarian attitudes, governance

According to psychologists, in addition to our physiological immune system, we also have a behavioral one: an unconscious code of conduct that helps us stay disease-free, including fear and avoidance of unfamiliar - and so possibly infected - people.

22 Sep 2021

Vaccines remain highly effective against new COVID-19 Delta variant

COVID-19 vaccines are effective at preventing hospitalizations and emergency department visits caused by the Delta variant, according to data from a national study.

13 Sep 2021

Expert warns people on the intake of livestock deworming drug to treat COVID-19

Rutgers Professor Lewis Nelson is available to discuss the dangers of people taking the livestock deworming drug ivermectin to try to treat COVID-19.

1 Sep 2021

Accurate diagnosis of bacterial superinfection pneumonia could help avoid antibiotic overuse

Only 21 percent of patients with severe pneumonia caused by SARS-CoV-2 (the virus that causes COVID-19) have a documented bacterial superinfection at the time of intubation, resulting in potential overuse of antibiotics, according to new research published online in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.

23 Aug 2021

Air pollution may increase chance of hospitalization for COVID-19 patients

Patients who have preexisting respiratory conditions such as asthma or chronic obstructive pulmonary disease (COPD) and live in areas with high levels of air pollution have a greater chance of hospitalization if they contract COVID-19, says a University of Cincinnati researcher.

15 Apr 2021

Slowdown in global warming led to lower malaria incidence in Ethiopia

The slowdown in global warming that was observed at the end of last century was reflected by a decrease in malaria transmission in the Ethiopian highlands, according to a study led by the Barcelona Institute for Global Health, an institution supported by "la Caixa" Foundation, and the University of Chicago.

11 Mar 2021

Air quality could influence the virulence and spread of COVID-19

The correlation between the high concentration of fine particles and the severity of influenza waves is well known to epidemiologists.

25 Nov 2020

TB vaccine research could benefit older people with type 2 diabetes

A study of older mice with type 2 diabetes has yielded highly promising results for researchers investigating potential new vaccines for tuberculosis (TB).

11 Aug 2020

COVID-19 Prevention Network announces two trials to evaluate monoclonal antibodies

The COVID-19 Prevention Network (CoVPN) today announced two Phase 3 trials to determine whether monoclonal antibodies (mAbs) can prevent SARS-CoV-2, the virus that causes COVID-19.

11 Aug 2020

New UK supply contract for COVID-19 sample collection kits

EKF Diagnostics Holdings plc, the AIM listed point-of-care business, announces that it has received an initial order worth £3 m from a partner from the private sector to supply PrimeStore MTM, a novel patented sample collection device, to be used in a COVID-19 testing programme for UK staff.

From EKF Diagnostics 5 Aug 2020

NIH clinical study to evaluate potential new therapeutics for mild, moderate COVID-19

A Phase 2 clinical trial will evaluate the safety and efficacy of potential new therapeutics for COVID-19, including an investigational therapeutic based on synthetic monoclonal antibodies (mAbs) to treat the disease.

5 Aug 2020

Broad antivirals can kill several types of coronaviruses in human cells and mice

team of scientists has engineered antiviral compounds that can kill several types of coronaviruses, including SARS-CoV-2, the virus that causes COVID-19.

4 Aug 2020

Rapid drug development yields potential treatment for yellow fever

Yellow fever, a hemorrhagic disease that is common in South America and sub-Saharan Africa, infects about 200,000 people per year and causes an estimated 30,000 deaths.

From Massachusetts Institute of Technology (MIT) 30 Jul 2020

Hybrid virus infects cells, interacts with antibodies just like COVID-19 virus

Airborne and potentially deadly, the virus that causes COVID-19 can only be studied safely under high-level biosafety conditions.

22 Jul 2020

UC Davis Health tests new antibody combination as potential treatment for COVID-19

Timothy Albertson, chair of internal medicine and specialist in pulmonary and critical care, is leading efforts at UC Davis Health to test a new antibody cocktail (REGN-COV2) as a prevention and treatment for COVID-19.

From The University of California, Davis 21 Jul 2020

Using blood samples to detect positive COVID-19 cases in 20 minutes

World-first research by Monash University in Australia has been able to detect positive COVID-19 cases using blood samples in about 20 minutes, and identify whether someone has contracted the virus.

20 Jul 2020

Viral load peaks in early stages of COVID-19, study shows

In a retrospective study, investigators from New York University Langone Health found that the quantity of SARS-CoV-2 (viral load) collected from patients in the emergency department is significantly higher in patients with fewer or milder symptoms who did not require hospitalization--the opposite of what might be expected.

15 Jul 2020

Study: LGBT-friendly medical practices can improve HIV and STD screening rates

This report--describing the first national quality improvement collaborative focused on providing culturally affirming care for LGBT people--finds that making primary care practices more LGBT-friendly and inclusive may improve STD and HIV screening rates among this vulnerable population.

15 Jul 2020

High amount of SARS-Cov-2 receptor is present in patients with pre-existing cardiac conditions

Nearly 20% of all COVID-19-associated deaths are from cardiac complications, yet the mechanisms from which these complications arise have remained a topic of debate in the cardiology community.

15 Jul 2020

Keck Medicine of USC participates in clinical trial to test antiviral drug as potential COVID-19 treatment

Keck Medicine of USC physicians are enrolling patients as part of an international clinical trial to evaluate the safety and efficacy of an antiviral drug, DAS181, as a possible treatment for hospitalized patients with severe COVID-19.

15 Jul 2020

Disease/Infection News

Study reveals strong link between infection rates and authoritarian attitudes, governance

Vaccines remain highly effective against new COVID-19 Delta variant

Expert warns people on the intake of livestock deworming drug to treat COVID-19

Accurate diagnosis of bacterial superinfection pneumonia could help avoid antibiotic overuse

Air pollution may increase chance of hospitalization for COVID-19 patients

Slowdown in global warming led to lower malaria incidence in Ethiopia

Air quality could influence the virulence and spread of COVID-19

TB vaccine research could benefit older people with type 2 diabetes

COVID-19 Prevention Network announces two trials to evaluate monoclonal antibodies

New UK supply contract for COVID-19 sample collection kits

NIH clinical study to evaluate potential new therapeutics for mild, moderate COVID-19

Broad antivirals can kill several types of coronaviruses in human cells and mice

Rapid drug development yields potential treatment for yellow fever

Hybrid virus infects cells, interacts with antibodies just like COVID-19 virus

UC Davis Health tests new antibody combination as potential treatment for COVID-19

Using blood samples to detect positive COVID-19 cases in 20 minutes

Viral load peaks in early stages of COVID-19, study shows

Study: LGBT-friendly medical practices can improve HIV and STD screening rates

High amount of SARS-Cov-2 receptor is present in patients with pre-existing cardiac conditions

Keck Medicine of USC participates in clinical trial to test antiviral drug as potential COVID-19 treatment

Driving Support for Pharmaceutical Testing Through Continuous Innovation

From Memory to Metaplasticity: Unraveling the Brain's Secrets

Revolutionizing Mass Spectrometry: A Deep Dive into Plasmion’s SICRIT® Technology

Latest in Genomics